The total return over the past 12 months is -64.71% vs. +16.94% for the S&P 500. So far it's up -63.29% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (64.71%) | (59.22%) | (56.46%) | (39.70%) | (26.38%) | N/A |
| Total Return CAGR | (64.71%) | (59.22%) | (56.46%) | (39.70%) | (26.38%) | N/A |
| Revenue CAGR | (80.43%) | (18.57%) | +2.86% | (18.08%) | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Evogene Ltd. (EVGN)
| Year | Start price | End price | EVGN Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $1.10 | $0.40 | (63.29%) | +14.51% | (77.80%) |
| 2025 | $1.87 | $1.10 | (41.18%) | +17.72% | (58.90%) |
| 2024 | $8.40 | $1.87 | (77.74%) | +24.89% | (102.63%) |
| 2023 | $7.00 | $8.40 | +20.00% | +26.19% | (6.19%) |
| 2022 | $16.40 | $7.00 | (57.32%) | (18.17%) | (39.15%) |
| 2021 | $47.00 | $16.40 | (65.11%) | +28.74% | (93.85%) |
| 2020 | $15.20 | $47.00 | +209.21% | +18.37% | +190.84% |
| 2019 | $19.80 | $15.20 | (23.23%) | +31.22% | (54.45%) |
| 2018 | $30.70 | $19.80 | (35.50%) | (4.56%) | (30.94%) |
| 2017 | $51.00 | $30.70 | (39.80%) | +21.70% | (61.50%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
